160 related articles for article (PubMed ID: 32003460)
1. Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies.
Trickey A; May MT; Gill MJ; Grabar S; Vehreschild J; Wit FWNM; Bonnet F; Cavassini M; Abgrall S; Berenguer J; Wyen C; Reiss P; Grabmeier-Pfistershammer K; Guest JL; Shepherd L; Teira R; d'Arminio Monforte A; Del Amo J; Justice A; Costagliola D; Sterne JAC
Int J Cancer; 2020 Jun; 146(11):3134-3146. PubMed ID: 32003460
[TBL] [Abstract][Full Text] [Related]
2. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
3. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
[TBL] [Abstract][Full Text] [Related]
4. Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.
Spagnuolo V; Galli L; Salpietro S; Gianotti N; Guffanti M; Cossarini F; Bigoloni A; Cinque P; Bossolasco S; Travi G; Fumagalli L; Lazzarin A; Castagna A
Int J Cancer; 2012 Jun; 130(12):2990-6. PubMed ID: 21796633
[TBL] [Abstract][Full Text] [Related]
5. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
Monforte Ad; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law M; De Wit S; Friis-Møller N; Phillips AN; Sabin CA; Lundgren JD;
AIDS; 2008 Oct; 22(16):2143-53. PubMed ID: 18832878
[TBL] [Abstract][Full Text] [Related]
6. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
7. The Spectrum of Malignancies among Adult HIV Cohort in Poland between 1995 and 2012: A Retrospective Analysis of 288 Cases.
Kowalski J; Cholewińska G; Pyziak-Kowalska K; Jabłonowska E; Barałkiewicz G; Grzeszczuk A; Leszczyszyn-Pynka M; Olczak A; Jankowska M; Mikuła T; Bociąga-Jasik M; Firląg-Burkacka E; Horban A
Contemp Oncol (Pozn); 2015; 19(3):226-35. PubMed ID: 26557764
[TBL] [Abstract][Full Text] [Related]
8. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
[TBL] [Abstract][Full Text] [Related]
9. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
10. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
[TBL] [Abstract][Full Text] [Related]
11. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
12. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study.
Franceschi S; Dal Maso L; Arniani S; Crosignani P; Vercelli M; Simonato L; Falcini F; Zanetti R; Barchielli A; Serraino D; Rezza G
Br J Cancer; 1998 Oct; 78(7):966-70. PubMed ID: 9764592
[TBL] [Abstract][Full Text] [Related]
13. Excess cancers among HIV-infected people in the United States.
Robbins HA; Pfeiffer RM; Shiels MS; Li J; Hall HI; Engels EA
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663691
[TBL] [Abstract][Full Text] [Related]
14. Impact of HIV status on prognosis of malignancies among people living with HIV in Japan.
Ando K; Shimomura A; Watanabe K; Tsukada K; Teruya K; Gatanaga H; Shimizu C
Cancer; 2024 May; ():. PubMed ID: 38718047
[TBL] [Abstract][Full Text] [Related]
15. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
Int J Cancer; 2015 Nov; 137(10):2443-53. PubMed ID: 25976897
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases.
Shiels MS; Koritzinsky EH; Clarke CA; Suneja G; Morton LM; Engels EA
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):274-81. PubMed ID: 24326629
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
Tsimberidou AM; Sarris AH; Medeiros LJ; Mesina O; Rodriguez MA; Hagemeister FB; Romaguera J; Pro B; McLaughlin P; Dang N; Cabanillas F
Leuk Lymphoma; 2001 May; 41(5-6):535-44. PubMed ID: 11378571
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Treatment, and Outcome of HIV-Associated Hematologic Malignancies in People Living with HIV in Sweden.
Kieri O; Marrone G; Sönnerborg A; Nowak P
AIDS Res Hum Retroviruses; 2022 Feb; 38(2):135-142. PubMed ID: 34652958
[TBL] [Abstract][Full Text] [Related]
20. Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?
Silverberg MJ; Abrams DI
Curr Opin HIV AIDS; 2009 Jan; 4(1):42-51. PubMed ID: 19339938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
